397 related articles for article (PubMed ID: 15766995)
1. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.
Ruggenenti P; Perna A; Loriga G; Ganeva M; Ene-Iordache B; Turturro M; Lesti M; Perticucci E; Chakarski IN; Leonardis D; Garini G; Sessa A; Basile C; Alpa M; Scanziani R; Sorba G; Zoccali C; Remuzzi G;
Lancet; 2005 Mar 12-18; 365(9463):939-46. PubMed ID: 15766995
[TBL] [Abstract][Full Text] [Related]
2. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
[TBL] [Abstract][Full Text] [Related]
3. Strict blood-pressure control and progression of renal failure in children.
; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
[TBL] [Abstract][Full Text] [Related]
4. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.
Ruggenenti P; Perna A; Gherardi G; Garini G; Zoccali C; Salvadori M; Scolari F; Schena FP; Remuzzi G
Lancet; 1999 Jul; 354(9176):359-64. PubMed ID: 10437863
[TBL] [Abstract][Full Text] [Related]
5. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
6. Renoprotective therapy: is it blood pressure or albuminuria that matters?
De Jong PE; de Zeeuw D
Lancet; 2005 Mar 12-18; 365(9463):913-4. PubMed ID: 15766975
[No Abstract] [Full Text] [Related]
7. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy.
Ruggenenti P; Perna A; Remuzzi G
J Am Soc Nephrol; 2001 Dec; 12(12):2832-2837. PubMed ID: 11729254
[TBL] [Abstract][Full Text] [Related]
9. The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study.
Herlitz H; Harris K; Risler T; Boner G; Bernheim J; Chanard J; Aurell M
Nephrol Dial Transplant; 2001 Nov; 16(11):2158-65. PubMed ID: 11682661
[TBL] [Abstract][Full Text] [Related]
10. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.
Wühl E; Mehls O; Schaefer F;
Kidney Int; 2004 Aug; 66(2):768-76. PubMed ID: 15253732
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment blood pressure reliably predicts progression of chronic nephropathies. GISEN Group.
Ruggenenti P; Perna A; Lesti M; Pisoni R; Mosconi L; Arnoldi F; Ciocca I; Gaspari F; Remuzzi G
Kidney Int; 2000 Nov; 58(5):2093-101. PubMed ID: 11044230
[TBL] [Abstract][Full Text] [Related]
13. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
14. The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension.
Bainbridge AD; Macfadyen RJ; Stark S; Lees KR; Reid JL
Br J Clin Pharmacol; 1993 Oct; 36(4):323-30. PubMed ID: 12959310
[TBL] [Abstract][Full Text] [Related]
15. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
[TBL] [Abstract][Full Text] [Related]
16. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).
Marre M; Lievre M; Chatellier G; Mann JF; Passa P; Ménard J;
BMJ; 2004 Feb; 328(7438):495. PubMed ID: 14960504
[TBL] [Abstract][Full Text] [Related]
17. ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1.
Perna A; Ruggenenti P; Testa A; Spoto B; Benini R; Misefari V; Remuzzi G; Zoccali C
Kidney Int; 2000 Jan; 57(1):274-81. PubMed ID: 10620209
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of a low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
Mervaala EM; Teräväinen TL; Malmberg L; Laakso J; Vapaatalo H; Karppanen H
Br J Pharmacol; 1997 Jun; 121(3):503-10. PubMed ID: 9179393
[TBL] [Abstract][Full Text] [Related]
19. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
20. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy.
Ruggenenti P; Perna A; Gherardi G; Gaspari F; Benini R; Remuzzi G
Lancet; 1998 Oct; 352(9136):1252-6. PubMed ID: 9788454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
